Home Top Movers Ra Medical Systems, Inc. (RMED) Stock Trending Up as DABRA Atherectomy Trial...

Ra Medical Systems, Inc. (RMED) Stock Trending Up as DABRA Atherectomy Trial Gains Traction

Ra Medical Systems, Inc. (RMED) stock prices were up by 9.26% as of market close on May 7th 2021, bringing the price per share up to USD$4.13 at the end of the trading day.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

DABRA Enrollment Progress

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

RMED recently announced an increase in enrolment for its pivotal clinical trial for DABRA, with a total of 42 subjects having been enrolled as of April 19th 2021. The trial is designed to evaluate the safety and efficacy of the DABRA laser system as an atherectomy device used in the treat of peripheral arterial disease (PAD).

Read More

DABRA Enrollment Status

The standing enrollment total is indicative of recent progress in the atherectomy trial, with 12 subjects having been updated since the previous trial update in March 2021. A running total of 5 clinical sites have thus far been cleared for enrollment in the study, while two additional sites are currently in varying stages of the qualification process.

501(k) FDA Clearance for DABRA

The U.S Drug and Food Administration granted 510(k) clearance to the DABRA excimer laser system in May 2017 for crossing chronic total occlusions (CTOs). The treatment is designed for the ablating of a channel in occlusive peripheral vascular disease in patients with symptomatic infrainguinallower extremity vascular disease.

U.S Market Value

Atherectomy, as defined by the U.S. FDA, includes a prespecified improvement to luminal patency. Third party research estimates have pegged the combined value of CTO and atherectomy markets in the U.S. alone to be roughly USD$900 million in 2021. Of this total, atherectomy represents a market of more than USD$750 million, as per the research estimates.

Atherectomy Trial Details

The open-label pivotal atherectomy clinical trial has an enrollment capacity of 100 subjects who exhibit symptoms of PAD, across a network of 10 enrollment sites. Among the outcome measures, safety, acute technical success and clinical success are primary objectives. The trial’s primary efficacy endpoint is the average decrease in percent diameter stenosis in each patient’s primary lesion. This is measured by angiograph immediately after treatment with DEBRA. The safety and clinical success endpoints for the trial are major adverse events at 30 days post-procedure and incidence of primary target lesion revascularization at 6 months post-procedure.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for RMED

With RMED’s progress in the atherectomy pivotal clinical trial, their proprietary DABRA treatment is on track towards commercialization. Such a significant addition to the company’s product portfolio is likely to usher in substantial and significant increases in shareholder value once it hits the market.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Tiziana Life Sciences Inc. (TLSA) stock surged during pre-market. Let’s see why?

Tiziana Life Sciences Inc. (NASDAQ: TLSA) stock declined by 2.54% at last close however the TLSA stock price depicts a rise of 8.26% during...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Related News

Patterson Companies Inc. (PDCO) stock plunged during current market, post financial results being released

Patterson Companies Inc. (NASDAQ: PDCO) stock declined by 8.97% in the current market trading session. Patterson Companies provides the newest products, technology, services, and...

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Why STAAR Surgical Company (STAA) stock went up on Tuesday?

STAAR Surgical Company (STAA) shares rose 5.84% in after-hours on Tuesday, June 22, 2021, and closed the day at $151.25 per share. earlier in...

Is Colony Capital Inc (CLNY) stock transformation resulted in a minor loss on Tuesday?

Colony Capital Inc. (CLNY) shares lost 0.94% on Tuesday, June 22, 2021, and closed at $8.42 per share. In the after-hours session, the CLNY...

Tupperware Brands Corp. (TUP) stock soar during pre-market trading. Here’s to know why?

Tupperware Brands Corp. (NASDAQ: TUP) stock gained by 0.3% at the last close while the TUP stock price surged by 6.83% in the pre-market...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

7542

GIFT

Download free eBook for 

7 GROWTH  STOCKS FOR 2021

WAIT 
WE HAVE GIFT FOR YOU

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam